Comgest Growth Emerging Markets GBP U Acc
Category Global Emerging Markets Equity
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
£25.98
£0.08 (+0.31%)
Fund Code
CEMUA
B40MC74
IE00B40MC740
Prices updated as at 12 Mar 2025
Prices in GBP
Investment objective
The investment objective of the Fund is to achieve capital appreciation by creating a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies based or operating in Emerging Markets. In pursuit of the Investment Objective, the Investment Manager intends investing in shares or equity linked securities including depositary receipts, preferred stock, convertible bonds and debentures which are convertible into equity securities, predominantly issued by companies having their headquarters or carrying out their predominant activities in Emerging Markets and quoted or traded on Regulated Markets.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Fund status | Open |
Fund type | Open Ended Investment Company |
Fund manager | David Raper, Slabbert van Zyl, Nicholas Morse |
27.78 | |
25.55 | |
Fund comparative index | MSCI EM NR USD |
Global Emerging Markets | |
- | |
1.10 | |
0.18 | |
0.00 | |
Global Emerging Markets Equity | |
No | |
Fund provider | Comgest Asset Management Intl Ltd |
Share class launch date | 12 Jan 2012 |
£337.00m | |
- | |
- | |
- | |
- |
Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.